See more : Sporting Clube de Portugal – Futebol, SAD (SCP.LS) Income Statement Analysis – Financial Results
Complete financial analysis of Sharps Technology, Inc. (STSS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Sharps Technology, Inc., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
You may be interested
- Key Capital Corporation (KCPC) Income Statement Analysis – Financial Results
- CBD Global Sciences Inc. (CBDNF) Income Statement Analysis – Financial Results
- Mountain Crest Acquisition Corp. II (MCADR) Income Statement Analysis – Financial Results
- Jong Shyn Shipbuilding Co., Ltd. (2644.TWO) Income Statement Analysis – Financial Results
- Swancor Holding Co., LTD. (3708.TW) Income Statement Analysis – Financial Results
Sharps Technology, Inc. (STSS)
About Sharps Technology, Inc.
Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 891.25K | 654.57K | 28.70K | 11.04K | 10.59K |
| Gross Profit | -891.25K | -654.57K | -28.70K | -11.04K | -10.59K |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 1.61M | 2.28M | 1.69M | 827.01K | 388.02K |
| General & Administrative | 8.52M | 6.46M | 2.81M | 1.51M | 1.51M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 1.66M |
| SG&A | 8.52M | 6.46M | 2.81M | 1.51M | 1.66M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 10.13M | 8.74M | 4.50M | 2.33M | 2.05M |
| Cost & Expenses | 10.13M | 8.74M | 4.50M | 2.33M | 2.06M |
| Interest Income | 0.00 | 1.32K | 769.00 | 3.33K | 3.60K |
| Interest Expense | 138.12K | 1.32M | 167.52K | 0.00 | 0.00 |
| Depreciation & Amortization | 891.25K | 654.57K | 28.70K | 11.04K | 10.59K |
| EBITDA | -8.98M | -2.66M | -4.47M | -2.33M | -2.04M |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -10.13M | -8.74M | -4.50M | -2.33M | -2.06M |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 255.01K | 4.10M | -166.75K | -6.87K | 3.59K |
| Income Before Tax | -9.87M | -4.64M | -4.66M | -2.34M | -2.06M |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -30.00K | -5.42M | 166.75K | 6.87K | 3.00 |
| Net Income | -9.84M | 779.89K | -4.83M | -2.35M | -2.06M |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.76 | 0.10 | -0.53 | -0.26 | -0.22 |
| EPS Diluted | -0.76 | 0.10 | -0.53 | -0.26 | -0.22 |
| Weighted Avg Shares Out | 13.03M | 8.10M | 9.17M | 9.17M | 9.17M |
| Weighted Avg Shares Out (Dil) | 13.03M | 8.10M | 9.17M | 9.17M | 9.17M |
Sharps Technology's CEO Issues Shareholder Letter Highlighting Hungary Manufacturing Facility Expansion Plans to Increase SecureGard and SoloGard Product Supply and Revenue
NEW YORK, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc., (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, issues a shareholder letter from Robert Hayes, the Company's Chief Executive Officer.
Sharps Regains Nasdaq Listing Compliance
NEW YORK, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: “STSS” and “STSSW”) (“Sharps”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, today announced that on November 13, 2024, the Company was notified by...
Sharps Technology, Inc. Announces Stockholders' Approval of Reverse Stock Split Ratio and Effective Date
NEW YORK, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: “STSS” and “STSSW”) ("Sharps"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, today announced that it will effect a one-for-22 reverse stock split...
Sharps Technology, Inc. Reminds Shareholders to Vote Before Important Shareholder Meeting on October 7, 2024
NEW YORK, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: STSS) (the “Company”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, is reminding shareholders to vote their proxy in favor of the Company's...
Aegis Capital Corp. Acted as Exclusive Placement Agent on a $3.5 Million Bridge Financing for Sharps Technology, Inc. (NASDAQ:STSS)
NEW YORK, NY / ACCESSWIRE / September 27, 2024 / Aegis Capital Corp. acted as Exclusive Placement Agent on a $3.5 Million Bridge Financing for Sharps Technology, Inc. (NASDAQ:STSS). About Sharps Technology, Inc. Sharps Technology, Inc., a medical device company,...
Sharps Technology, Inc. Closes $3.5 Million Bridge Financing
NEW YORK, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: STSS) (the “Company”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, today announced the closing of its previously announced secured bridge loan financing...
Sharps Technology, Inc. Announces $3.5 Million Bridge Financing
NEW YORK, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: STSS) (the “Company”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, today announced that it has entered into definitive agreements with institutional investors...
Sharps Technology Announces Continued Listing on Nasdaq Pending Results of an Upcoming Special Shareholders' Meeting
NEW YORK, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc., (NASDAQ: STSS and STSSW) (“Sharps Technology” or the “Company”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, announced today that the Company has secured...
Sharps Technology CEO Urges Shareholders to Vote in Support of the Three Proposals by the July 12 Voting Deadline
Robert Hayes issues a letter to shareholders asking their voting approval on three proposals vital to the Company's continued growth.
Nasdaq Surges Over 100 Points; Sharps Technology Shares Spike Higher
U.S. stocks traded mostly higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Friday.
Source: https://incomestatements.info
Category: Stock Reports